All Stories

  1. Procedural technique development in radiation oncology
  2. Pediatric Radiotherapy Utilization rate (PUR) in a large pediatric oncology center in Low-/Middle-Income country (LIMC): Report on 14473 patients
  3. Dosimetric comparison between intensity modulated radiotherapy and three-dimensional conformal radiotherapy in adjuvant setting after radical cystectomy in high-risk urothelial bladder cancer
  4. Palliative and end-of-life symptoms management for children with diffuse intrinsic pontine glioma
  5. Adjuvant and Neoadjuvant Radiation Therapy for Locally Advanced Bladder Cancer
  6. Radiation Oncology in the Arab World
  7. Efficacy of re-irradiation in progressive diffuse intrinsic pontine glioma
  8. Urinary schistosomiasis and the associated bladder cancer: update
  9. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients
  10. Prospective trial of adjuvant chemotherapy versus adjuvant radiation therapy for locally advanced bladder cancer after radical cystectomy.
  11. Pediatric diffuse intrinsic pontine glioma: where do we stand?
  12. Is economic status the main determinant of radiation therapy availability? The Arab world as an example of developing countries
  13. Randomized Trial of Adjuvant Therapies after Radical Cystectomy for Locally Advanced Bladder Cancer: Squamous Cell Carcinoma Subgroup Analysis
  14. PB2000 OUTCOME OF PEDIATRIC NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA, IS ABVD THE BEST REGIMEN? 10 YEARS SINGLE CENTER EXPERIENCE, REPORT FROM CHILDREN CANCER HOSPITAL, EGYPT.
  15. Randomized trial of adjuvant chemotherapy versus adjuvant radiation therapy for locally advanced bladder cancer after radical cystectomy.
  16. Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis.
  17. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy
  18. Radiation Therapy Availability in Africa and Latin America: Two Models of Low and Middle Income Countries
  19. Multidisciplinary Treatment of Pediatric Low-Grade Glioma: Experience of Children Cancer Hospital of Egypt; 2007-2012
  20. Radiation Oncology in Egypt: A Model for Africa
  21. Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt
  22. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy
  23. Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder
  24. The shift from delayed radiotherapy to localized radiotherapy strategy in treatment of infantile medulloblastoma – challenging experience from LMIC
  25. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt
  26. Adjuvant Sandwich Chemotherapy and Radiation Versus Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer
  27. Pediatric Neuro-Oncology in Low-/Middle-Income Countries
  28. In Regard to Reddy et al
  29. The Optimal Dose of Hypofractionated Radiotherapy in Diffuse Intrinsic Pontine Glioma
  30. Management Of Locally Advanced And Metastatic Pediatric Nasopharyngeal Carcinoma. Experience Of Children Cancer Hospital – Egypt
  31. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries
  32. More Effort is Needed to Improve the Practice of Radiotherapy in Africa
  33. Clear cell sarcoma of the kidney: Patients' characteristics and improved outcome in developing countries
  34. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A randomized controlled trial
  35. Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt, experience
  36. Bladder cancer and schistosomiasis
  37. Hypofractionated Radiotherapy for Pediatric Diffuse Intrinsic Pontine Glioma (DIPG): A Prospective Controlled Randomized Trial
  38. Re-evaluation of the value of adjunctive modern radiotherapy in muscle-invasive bladder cancer
  39. 4118 POSTER Prospective Randomized Trial of Hypofractionated Conformal Radiotherapy for Pediatric Diffuse Pontine Glioma
  40. The need to revisit adjuvant and neoadjuvant radiotherapy in bladder cancer
  41. Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited
  42. Radiation Oncology Facilities in Africa: What Is the Most Important: Equipment, Staffing, or Guidelines?
  43. Does Schistosoma-associated bladder cancer differ from urothelial cancer? Proof from the laboratory and clinic
  44. A Tribute to the Father of Radiation Oncology and Radiobiology in Egypt and the Arab World: Professor Hassan K. Awwad
  45. Adjuvant radiotherapy in bladder cancer: Time to take a fresh look?
  46. Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients
  47. Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer
  48. A phase III randomized controlled trial of adjuvant chemoradiotherapy (CRT) and postoperative radiotherapy (PORT) versus PORT alone in high risk bladder cancer patients
  49. Adjuvant chemoradiotherapy with gemcitabine and cisplatin and postoperative radiotherapy (PORT) versus PORT alone in high risk bladder cancer patients. A phase III randomized controlled trial
  50. Prognostic implication of apoptosis and angiogenesis in cervical uteri cancer
  51. 2166 Prognostic implication of apoptosis and angiogenesis in cervical uteri cancer
  52. Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor
  53. Radiation as adjunctive therapy to cysteccomy for bladder cancer: Is there a difference for Bilharzial association?
  54. Dysgerminoma of the ovary: good prognosis even in advanced stages
  55. Postoperative radiotherapy of carcinoma in bilharzial bladder. Improved disease-free survival through improving local control
  56. Postoperative radiotherapy of carcinoma in bilharzial bladder using a three-fractions per day regimen